Literature DB >> 19465537

Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial.

Heather M Conklin1, Susan Helton, Jason Ashford, Raymond K Mulhern, Wilburn E Reddick, Ronald Brown, Melanie Bonner, Bruce W Jasper, Shengjie Wu, Xiaoping Xiong, Raja B Khan.   

Abstract

OBJECTIVE: To investigate the methylphenidate (MPH) response rate among childhood survivors of acute lymphoblastic leukemia (ALL) and brain tumors (BTs) and to identify predictors of positive MPH response.
METHODS: Cancer survivors (N = 106; BT = 51 and ALL = 55) identified as having attention deficits and learning problems participated in a 3-week, double-blind, crossover trial consisting of placebo, low-dose MPH (0.3 mg/kg), and moderate-dose MPH (0.6 mg/kg). Weekly teacher and parent reports on the Conners' Rating Scales were gathered.
RESULTS: Following moderate MPH dose, 45.28% of the sample was classified as responders. Findings revealed that more problems endorsed prior to the medication trial on parent and teacher ratings were predictive of positive medication response (p < .05).
CONCLUSIONS: MPH significantly reduces attention problems in a subset of childhood cancer survivors. Parent and teacher ratings may assist in identifying children most likely to respond to MPH so prescribing may be optimally targeted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465537      PMCID: PMC2902831          DOI: 10.1093/jpepsy/jsp044

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  46 in total

Review 1.  Pediatric psychopharmacotherapy: a review of recent research.

Authors:  K D Gadow
Journal:  J Child Psychol Psychiatry       Date:  1992-01       Impact factor: 8.982

Review 2.  Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.

Authors:  Aaron P Gibson; Tawny L Bettinger; Nick C Patel; M Lynn Crismon
Journal:  Ann Pharmacother       Date:  2006-05-30       Impact factor: 3.154

Review 3.  Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations.

Authors:  Mark L Wolraich; Laura McGuinn; Melissa Doffing
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 4.  Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Authors:  Ronald T Brown; Robert W Amler; Wendy S Freeman; James M Perrin; Martin T Stein; Heidi M Feldman; Karen Pierce; Mark L Wolraich
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

Review 5.  Methylphenidate treatment.

Authors:  Peter Weber; Jürg Lütschg
Journal:  Pediatr Neurol       Date:  2002-04       Impact factor: 3.372

6.  Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.

Authors:  L L Greenhill; J M Swanson; B Vitiello; M Davies; W Clevenger; M Wu; L E Arnold; H B Abikoff; O G Bukstein; C K Conners; G R Elliott; L Hechtman; S P Hinshaw; B Hoza; P S Jensen; H C Kraemer; J S March; J H Newcorn; J B Severe; K Wells; T Wigal
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-02       Impact factor: 8.829

Review 7.  Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.

Authors:  S R Pliszka
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

Review 8.  Long-term neurobehavioral outcome in pediatric brain-tumor patients: review and methodological critique.

Authors:  M D Ris; R B Noll
Journal:  J Clin Exp Neuropsychol       Date:  1994-02       Impact factor: 2.475

9.  Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial.

Authors:  Heather M Conklin; Raja B Khan; Wilburn E Reddick; Susan Helton; Ronald Brown; Scott C Howard; Melanie Bonner; Robbin Christensen; Shengjie Wu; Xiaoping Xiong; Raymond K Mulhern
Journal:  J Pediatr Psychol       Date:  2007-06-14

10.  A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy.

Authors:  Robert W Butler; Donna R Copeland; Diane L Fairclough; Raymond K Mulhern; Ernest R Katz; Anne E Kazak; Robert B Noll; Sunita K Patel; Olle Jane Z Sahler
Journal:  J Consult Clin Psychol       Date:  2008-06
View more
  17 in total

1.  Mathematics intervention for prevention of neurocognitive deficits in childhood leukemia.

Authors:  Ida M Moore; Marilyn J Hockenberry; Cynthia Anhalt; Kathy McCarthy; Kevin R Krull
Journal:  Pediatr Blood Cancer       Date:  2011-09-21       Impact factor: 3.167

2.  Parent and teacher ratings of attention during a year-long methylphenidate trial in children treated for cancer.

Authors:  Kelli L Netson; Heather M Conklin; Jason M Ashford; Lisa S Kahalley; Shengie Wu; Xiaoping Xiong
Journal:  J Pediatr Psychol       Date:  2010-11-19

3.  Symptoms of attention-deficit/hyperactivity disorder in long-term survivors of childhood leukemia.

Authors:  Kevin R Krull; Raja B Khan; Kirsten K Ness; Davonna Ledet; Liang Zhu; Ching-Hon Pui; Scott C Howard; Deo Kumar Srivastava; Noah D Sabin; Melissa M Hudson; E Brannon Morris
Journal:  Pediatr Blood Cancer       Date:  2011-01-28       Impact factor: 3.167

4.  Feasibility and acceptability of a remotely administered computerized intervention to address cognitive late effects among childhood cancer survivors.

Authors:  Lauren E Cox; Jason M Ashford; Kellie N Clark; Karen Martin-Elbahesh; Kristina K Hardy; Thomas E Merchant; Robert J Ogg; Sima Jeha; Victoria W Willard; Lu Huang; Hui Zhang; Heather M Conklin
Journal:  Neurooncol Pract       Date:  2015-03-13

5.  Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia.

Authors:  Amanda L Winter; Heather M Conklin; Vida L Tyc; Heather Stancel; Pamela S Hinds; Melissa M Hudson; Lisa S Kahalley
Journal:  J Clin Exp Neuropsychol       Date:  2014-08-15       Impact factor: 2.475

6.  Long-Term Efficacy of Computerized Cognitive Training Among Survivors of Childhood Cancer: A Single-Blind Randomized Controlled Trial.

Authors:  Heather M Conklin; Jason M Ashford; Kellie N Clark; Karen Martin-Elbahesh; Kristina K Hardy; Thomas E Merchant; Robert J Ogg; Sima Jeha; Lu Huang; Hui Zhang
Journal:  J Pediatr Psychol       Date:  2017-03-01

7.  Computerized Cognitive Training for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors: A Randomized Controlled Trial.

Authors:  Heather M Conklin; Robert J Ogg; Jason M Ashford; Matthew A Scoggins; Ping Zou; Kellie N Clark; Karen Martin-Elbahesh; Kristina K Hardy; Thomas E Merchant; Sima Jeha; Lu Huang; Hui Zhang
Journal:  J Clin Oncol       Date:  2015-10-12       Impact factor: 44.544

8.  Disseminability of computerized cognitive training: Performance across coaches.

Authors:  Ashley S Fournier-Goodnight; Jason M Ashford; Kellie N Clark; Karen Martin-Elbahesh; Kristina K Hardy; Thomas E Merchant; Sima Jeha; Robert J Ogg; Hui Zhang; Lei Wang; Heather M Conklin
Journal:  Appl Neuropsychol Child       Date:  2017-11-21       Impact factor: 1.493

9.  Risky sexual behavior in adolescent survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  James L Klosky; Rebecca H Foster; Zhenghong Li; Courtney Peasant; Carrie R Howell; Ann C Mertens; Leslie L Robison; Kirsten K Ness
Journal:  Health Psychol       Date:  2013-12-23       Impact factor: 4.267

10.  Working memory training in survivors of pediatric cancer: a randomized pilot study.

Authors:  Kristina K Hardy; Victoria W Willard; Taryn M Allen; Melanie J Bonner
Journal:  Psychooncology       Date:  2012-12-02       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.